Poland· PL-100026019
Gastrolit
A oral rehydration salt formulations product containing produkt złożony, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Produkt złożony is registered in 5 of 19 countries.
Countries holding a registration under ATC A07CA (oral rehydration salt formulations), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Produkt złożony · ATC A07CA
5 / 19 countries
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Produkt złożony
- Manufacturer
- Teva Pharmaceuticals Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A07CA
- ATC class
- Oral rehydration salt formulations
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990012312
- gtin05908289660593
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A07CA
Oral rehydration salt formulations, as other registers publish it.
- FinlandDiarolOrion Corporation Orion Pharma
- IrelandDioralyte Blackcurrant Powder for Oral SolutionPhoenix Labs
- IrelandDioralyte Citrus Powder for Oral SolutionPhoenix Labs
- NorwayDioralyte NaturalAventis Pharma
- IrelandDioralyte Natural, Powder for oral solutionPhoenix Labs
- IrelandDioralyte Rebalance Blackcurrant Powder for Oral SolutionPhoenix Labs
- IrelandDioralyte Rebalance Citrus Powder for Oral SolutionPhoenix Labs
- IrelandDioralyte Rebalance Natural Powder for Oral SolutionPhoenix Labs
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da9fe2b5-3a53-448b-b315-9590381e067f GET /v1/drugs/da9fe2b5-3a53-448b-b315-9590381e067f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu",
"source": "urpl",
"strength": "-",
"packaging": "05909990012312 ¦ OTC ¦ 4176\n15 sasz. \n05908289660593 ¦ OTC ¦ 136931\n14 sasz.",
"substance": "Natrii hydrogenocarbonas 500 mg/saszetkę + Kalii chloridum 300 mg/saszetkę + Natrii chloridum 350 mg/saszetkę + Glucosum 2980 mg/saszetkę + Chamomillae extractum (etanolowy) 20 mg/saszetkę",
"common_name": "Produkt złożony",
"pl_product_id": "100026019",
"pozwolenie_nr": "00123",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about produkt złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.